Significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma

American Journal of Surgical Pathology

Volumn 20, Issue 11, 1996, Pages 1351-1360

  McNeal, John E ^a   Yemoto, Cheryl E M ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Metastasis; Prostatic carcinoma; Vascular invasion

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; TUMOR VOLUME; VASCULAR TUMOR;

ADENOCARCINOMA; ADULT; AGED; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0029910817     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199611000-00006     Document Type: Article

References (17)

1. Akslen LA. Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer 1993;72:2680-5.
2. Bahnson RR, Dresner SM, Gooding W, Becich MJ. Incidence and prognostic significance of lymphatic and vascular invasion in radical prostatectomy specimens. Prostate 1989;15:149-55.
3. Clemente CG, Borachhi P, Andreola S, Del Vecchio M, Veronesi P, Rilke FO. Peritumoral lymphatic invasion in patients with nodenegative mammary duct carcinoma. Cancer 1992;69:1396-403.
4. Davis BW, Gelber R, Goldhirsch A, et al. Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Hum Pathol 1995;16:1212-8.
5. Fallowfield ME, Cook MG. Vascular invasion in malignant melanomas: an independent prognostic variable? Am J Surg Pathol 1989;13:217-20.
6. Fidler IJ. Critical factors in the biology of human cancer metastasis. Cancer Res 1990;50;6130-8.
7. Gabbert HE, Meier S, Gerharz DC, Hommel G. Tumor-cell dissociation at the invasion front: A new prognostic parameter in gastric cancer patients. Int J Cancer 1992;50:202-7.
8. Gleason DF. Histologic grading of prostate cancer: a perspective, Hum Pathol 1992;23:273-9.
9. Kamura T, Tsukamoto N, Tsuruchi N, et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 1992;69:181-6.
10. Lee AKC, DeLellis RA, Silverman ML, Wolfe HJ. Lymphatic and blood vessel invasion in breast carcinoma. Hum Pathol 1986; v17:984-7.
11. McNeal JE, Reese JH, Redwine EA, Freiha FS, Stamey TA. Cribriform adenocarcinoma of the prostate. Cancer 1988;58:1714-9.
12. McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Capsular penetration in prostate cancer: singificance for natural history and treatment. Am J Surg Pathol 1990;14:240-7.
13. McNeal JE, Yemoto CEM. The spread of adenocarcinoma within prostatic ducts and acini: morphologic and clinical correlations. Am J Surg Pathol 1996;20:802-14.
14. Prestigiacomo AF, Stamey TA. A comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. J Urol 1994;152:1515-9.
15. Roberts TE, Hasleton PS, Musgrove C, Swindell R, Lawson RAM. Vascular invasion in non-small cell lung carcinoma. Clin Pathol 1992;45:591-3.
16. Rosen PP. Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis and clinical significance. Pathol Annu 1983;18:218-32.
17. Salomao DR, Graham SD, Bostwick DG. Microvascular invasion in prostate cancer correlates with pathologic stage. Arch Pathol Lab Med 1995;119:1050-4.